The New England Journal of Medicine
HOME   |   PAST ISSUES   |   TOPIC COLLECTIONS   |    Advanced Search
E-mail Icon  FREE NEJM E-TOC   CME  |  Physician Jobs  |  Subscribe
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
Services
- Subscribe
- Renew
- Register
- Submit a Manuscript or Letter

Information For
- Authors
- Customers
- Institutions/Libraries
- Reviewers
About NEJM
Closed Folder IconNEJM Tools
CME
Personal Archive
PDA Services
E-Mail Alerts
Physician Jobs
Edit Your Information
Access Outside U.S.
Features at nejm.org
Convention Schedule
Closed Folder IconNEJM Information
Privacy Policy
Reprints
Editors & Publishers
Permissions Info
Editorial Policies
Advertising Policies
Copyright
Terms
- See All Features
- Contact Us
Go to handheld.nejm.org NEJM Mobile
NEJM RSS Feeds Article Feeds

 
NEJM's E-Mail Table of Contents -- Sign Up Now for Free

Advertisement



 

Current IssueMay 15, 2008
FULL TABLE OF CONTENTS | THIS WEEK IN THE JOURNAL | Audio Icon AUDIO SUMMARY
Original Article
graphic Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
Initial therapy with efavirenz plus two NRTIs was associated with less virologic failure than was lopinavir–ritonavir plus two NRTIs. The NRTI-sparing regimen of lopinavir–ritonavir plus efavirenz had virologic efficacy similar to that of efavirenz plus two NRTIs but was more likely to select for drug resistance.   CME Exam
Original Article
graphic Aprotinin versus Lysine Analogues in High-Risk Cardiac Surgery
In patients undergoing high-risk cardiac surgery, aprotinin was somewhat more effective than either aminocaproic acid or tranexamic acid in reducing massive perioperative bleeding but at the expense of a higher rate of death. Aprotinin cannot be recommended to control blood loss in this clinical setting.
Online FirstMay 14, 2008 (DOI: 10.1056/NEJMoa0802395), in Print May 29, 2008
-Related Editorial: The Aprotinin Story — Is BART the Final Chapter?
Original Article
Biomarkers to Predict Death from Cardiovascular Causes
To predict the risk of death from cardiovascular causes in elderly men, the authors used a combination of biomarkers (troponin I, N-terminal pro–brain natriuretic peptide, cystatin C, and C-reactive protein). The addition of these markers to a model with traditional cardiovascular risk factors significantly improved risk stratification.
Original Article
graphic Cardiac Troponin in Acute Heart Failure
Patients hospitalized with acute decompensated heart failure who had elevated cardiac troponin levels had higher mortality rates than those who were negative for troponin. Measurement of cardiac troponin, which may reflect myocyte injury, is useful for risk stratification of such patients.   CME Exam
Original Article
graphic Recombinant Factor VIIa for Intracerebral Hemorrhage
In this phase 3 trial, recombinant activated factor VII (rFVIIa) reduced hematoma growth but did not improve clinical outcomes in patients with intracerebral hemorrhage.
Clinical Practice
graphic Rotator-Cuff Failure
A 63-year-old woman presents with a 2-year history of progressive weakness and discomfort in her right shoulder. MRI shows a large defect in the rotator cuff. How should her case be managed?
Audio IconListen to the full text of this article.
Medical Progress
graphic Biomarkers in Heart Failure
This review focuses on biomarkers for heart failure other than routinely determined laboratory values and discusses how these might be used in assessing and managing heart failure.
Case Records of the Massachusetts General Hospital
graphic A Man with an Elevated PSA Level and Early-Stage Prostate Cancer
A 55-year-old man was evaluated for management of prostate cancer. An elevated serum prostate-specific antigen level was found; core needle biopsies of the prostate disclosed adenocarcinoma, with a Gleason score of 6 out of 10. CT showed a smoothly enlarged prostate.   CME Exam
Clinical Decisions
graphic Management of Carotid Stenosis — Polling Results
This interactive feature presented the case of a patient with carotid stenosis. Readers were invited to vote for one of three possible treatment options. Polling results are now available, including results by country (see interactive map) and over 250 comments from readers.   Free Full Text
Perspective
DTCA for PTCA — Crossing the Line in Consumer Health Education?
On November 22, 2007, television viewers witnessed the launch of the first direct-to-consumer advertising campaign for percutaneous transluminal coronary angioplasty with a drug-eluting coronary stent. Drs. William Boden and George Diamond ask, has industry crossed the line this time?
Online FirstMay 14, 2008 (DOI: 10.1056/NEJMp0801433), in Print May 22, 2008
Perspective
Vaccines and Autism Revisited — The Hannah Poling Case
Hannah Poling was diagnosed with encephalopathy caused by a mitochondrial enzyme deficit. Her parents believed that vaccines had triggered her encephalopathy, and they sued the Department of Health and Human Services for compensation under the Vaccine Injury Compensation Program and won. Dr. Paul Offit writes that the Poling case is best understood in the context of the decision-making process of this unusual vaccine court.   Free Full Text
Perspective
graphic Like Night and Day — Shedding Light on Off-Hours Care
Dr. David Shulkin has begun making late-night administrative rounds at the hospital where he is president and chief executive officer. These visits are part of an initiative intended to address the stark discrepancy in quality between daytime and nighttime inpatient services.   Free Full Text

Editorials
Initial Treatment for HIV Infection — An Embarrassment of Riches

Multiple Biomarker Panels for Cardiovascular Risk Assessment

Intracerebral Hemorrhage — Improving Outcome by Reducing Volume?

Correspondence
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq  Free Full Text

Outcomes 18 Months after the First Human Partial Face Transplantation
Free Full Text

Selective Publication of Antidepressant Trials

Physicians and Execution  Free Full Text

Perspective Roundtable: Lethal Injection  Free Full Text

Letting the Genome Out of the Bottle  Free Full Text

Serotonin Syndrome and Triptan Monotherapy

Upcoming in Print
Published Online May 7, 2008
-Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
Published Online April 29, 2008
-Multiple Genetic Loci for Bone Mineral Density and Fractures
Published Online April 27, 2008
-Gene Therapy for Leber’s Congenital Amaurosis
Published Online April 23, 2008
-Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
FULL TABLE OF CONTENTS | THIS WEEK IN THE JOURNAL | Audio Icon AUDIO SUMMARY
Image of the Week

graphic

Early Satiety

This 24-year-old woman presented with a history of progressive abdominal distention accompanied by early satiety and constipation.

-Recent Featured Images

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society.
All rights reserved. Electronic ISSN 1533-4406 Print ISSN 0028-4793.
The content of this site is intended for health care professionals.

 
HOME  |  PAST ISSUES  |   TOPIC COLLECTIONS  |   SEARCH  |  beta.nejm.org
 

The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. Material is published with an emphasis on internal medicine and specialty areas including allergy/immunology, cardiology, endocrinology, gastroenterology, hematology, kidney disease, oncology, pulmonary disease, rheumatology, HIV, and infectious diseases.

NEJM Online contains both the current issue and an online archive that can be accessed through browsing, advanced searching, or collections by disease or topic.
Subscriber services include PDA content access, PowerPoint downloads, and continuing medical education (CME).